Peptide Atlas — health, wellness & peptide resources
Peptide Library
Sleep Research

DSIP

Also referenced as: Delta sleep-inducing peptide

A nonapeptide isolated from rabbit brain in the 1970s, still discussed for sleep despite inconsistent evidence.

Evidence grade
DPreclinical Research

Preclinical Research

Regulatory status
Not FDA Approved
Human data
Limited

No registered clinical trials identified

Last reviewed
September 1, 2026

Overview

DSIP was isolated from the cerebral venous blood of sleeping rabbits and named for its apparent ability to induce delta-wave sleep.

Subsequent human work produced inconsistent results, and the compound never entered clinical use. It remains a good case study in how an evocative name outlives the evidence.

Why It's Being Studied

  • Sleep architecture and delta-wave activity.
  • Chronic pain and withdrawal syndromes in older clinical reports.
  • Stress hormone and circadian regulation.

Mechanism of Action

In plain language

It was found in the blood of sleeping animals and appeared to promote deep sleep, though later studies did not confirm a reliable effect.

Technical detail

Mechanistic proposals include modulation of somatostatin and corticotropin-releasing hormone signalling, effects on delta-wave EEG activity, and interaction with opioid and stress-axis pathways. No receptor has been definitively identified.

Interactive diagram

The sleep cycle

Tap each stage to see what happens.

Wake: Sleep pressure (adenosine) builds through the day.

Background: Sleep Research

Sleep research measures sleep stages with polysomnography and asks whether a signal changes how quickly people fall asleep, how deeply they sleep, or how rested they feel.

Early sleep-peptide research dates back decades and has never produced consistent, replicated human results.

Research Areas & Routes Studied

Areas studied
  • Sleep architecture
  • Stress hormones
  • Pain
Routes used in research
  • Subcutaneous injection (research)
  • Intravenous (older clinical studies)

Evidence Summary

Older human studies exist but are small, inconsistent and decades old; the bulk of the literature is animal and mechanistic.

Evidence pyramid

Higher tiers carry more weight. Filled tiers have evidence for DSIP; tap to read it.

Human clinical trials
  • Small studies from the 1980s and 1990s reported effects on sleep latency and chronic pain; results were inconsistent and not replicated in modern trials.
Source breakdown

1 cited sources.

  • Narrative review1

Human clinical evidence

  • Small studies from the 1980s and 1990s reported effects on sleep latency and chronic pain; results were inconsistent and not replicated in modern trials.

Animal studies

  • EEG and behavioural studies in rodents and rabbits.

Anecdotal / community information

  • Community sleep reports are uncontrolled and subject to strong placebo effects.

Reported Adverse Events in Research

  • Limited safety data; older studies reported few adverse events in small samples.

Limitations of Current Evidence

  • Evidence is old, small and inconsistent.
  • No established human dosing protocol exists.

How to Read This Research

Questions to ask
  • Was sleep measured in a lab or by self-report or wearable?
  • Was the population healthy sleepers or people with diagnosed insomnia?
Reading tips
  • Placebo effects in subjective sleep outcomes are substantial.
  • Consumer wearables estimate sleep stages; they do not measure them directly.
Polysomnography
A lab sleep study measuring brain waves, breathing and movement.
Sleep latency
Time taken to fall asleep.
Slow-wave sleep
The deepest non-REM sleep stage.

Compare With Other Compounds

Compare side by side
DSIPSemaglutide
Evidence gradeD — Preclinical ResearchA — Strong Clinical Evidence
Regulatory statusNot FDA ApprovedFDA Approved for Specific Indication
Human dataLimitedYes
Clinical trialsNone identifiedRegistered trials exist
Research routesSubcutaneous injection (research), Intravenous (older clinical studies)Subcutaneous injection, Oral tablet (approved form)
Cited sources14

Frequently Asked Questions

Why It Is Used

  • Sleep

    Sleep Onset and Sleep Depth

    Delta sleep-inducing peptide has the most promising name and some of the thinnest evidence on this site. That contrast is instructive.

    Read the case study

Research References

  • Narrative review

    Delta sleep-inducing peptide: physiological and clinical studies

    View Study
This page is an educational research summary. It is not medical advice, does not recommend human use, and does not provide individualised dosing. Many compounds discussed here are research use only and are not approved medicines.